Tetrahydrofuro [3 4-D] dioxolane compounds for use in the treatment of viral infections and cancer

Details for Australian Patent Application No. 2008251555 (hide)

Owner BioCryst Pharmaceuticals, Inc.

Inventors Babu, Yarlagadda S.; Chand, Pooran

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008251555

PCT Pub. Number WO2008/141079

Priority 60/917,210 10.05.07 US; 60/940,125 25.05.07 US

Filing date 8 May 2008

Wipo publication date 20 November 2008

Acceptance publication date 30 August 2012

International Classifications

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/141079 Priority application(s): WO2008/141079

30 August 2012 Application Accepted

  Published as AU-B-2008251555

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251556-Membrane module with multiple bottom headers and filtration process

2008251535-Lung volume reduction therapy using crosslinked non-natural polymers